Clinical Trial Update: Mifepristone 2.5, 5, 10 mg Versus Placebo in the Treatment of Endometriosis [Phase 2, Phase 3]

View source ↗

Summary

This entry reports a completed Phase 2/3 clinical trial comparing mifepristone at 2.5, 5, and 10 mg versus placebo for the treatment of endometriosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• Mifepristone (mifepristone)

Snippet

Sponsor: Mediterranea Medica S. L. | Conditions: Endometriosis | Phase 2, Phase 3 | Status: COMPLETED